LEA29Y (Belatacept) Emory Edmonton Protocol

Bio2RDF uri

LEA29Y (Belatacept) Emory Edmonton Protocol

http://bio2rdf.org/clinicaltrials:NCT00468403

Bio2RDF identifier

NCT00468403

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00468403

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00468403

acronym [clinicaltrials_vocabulary:acronym]

LEEP

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

Type 1 diabetes is an a ...... hypoglycemic episodes.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

LEA29Y (Belatacept) Emory Edmonton Protocol

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:2a917ac4ccdbaae07aca32ccbe15edaa]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:0eb48577c393abfbce7dfbec1ad505e6]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:10387779c2f5636900079f8c7a255bab]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:15f46c2b16a180311b2ce5a9181730f1]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:1eca60df57c33436db1d16e034c4476b]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:20191c56669a48b7d13641b205bc73ba]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:2a64085af87b4dd2b1316f9a56db9038]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:32825a174f221834753a0926c4a7d75c]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:3fa11dac27b8a5d4494891df43255f75]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:5a5864550e0c9371bc7e93e1d458b3d8]

Proportion of subjects with insulin independence 75 days after first islet transplant [clinicaltrials_resource:5c8673c6f22c7d931e447bbd27262cd5]

collaborator [clinicaltrials_vocabulary:collaborator]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

completion date [clinicaltrials_vocabulary:completion-date]

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Type 1 Diabetes Mellitus [clinicaltrials_resource:b31a062745e0dde53632426b9e7c69cc]

condition browse [clinicaltrials_vocabulary:condition-browse]

Diabetes Mellitus, Type 1 [clinicaltrials_resource:206def59d690d8aa1ae6d3886db270e7]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Diabetes Mellitus, Type 1 [clinicaltrials_resource:206def59d690d8aa1ae6d3886db270e7]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

detailed description [clinicaltrials_vocabulary:detailed-description]

Type 1 diabetes is comm ...... articipant's last transplant.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00468403 [clinicaltrials_resource:7bd8df3a95e3933f39d60baa30342754]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Belatacept [clinicaltrials_resource:147e9f9122ab9d893a0e3e069e79d388]

Tacrolimus [clinicaltrials_resource:5e2128717997681077fb6bdf974731a3]

Mycophenolate Mofetil [clinicaltrials_resource:81cdcf042613fb20827798f4737d56d4]

Basiliximab [clinicaltrials_resource:9fc0ae0afc90cb89fee32ebdb5863bac]

Intraportal infusion of islet cells [clinicaltrials_resource:a4b80bb7c41ae2a0b6fa95a2252aaa4c]

Allogeneic Pancreatic Islet Cells [clinicaltrials_resource:c403670b5b7ca1cb1c74ca1c45369f7f]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Tacrolimus [clinicaltrials_resource:27326813125e85301cd643b58287f20b]

Mycophenolate mofetil [clinicaltrials_resource:31de209b7264303fdda3c8b57bf0b039]

Immunosuppressive Agents [clinicaltrials_resource:61be1390f37d00d3f418c5254c345920]

Basiliximab [clinicaltrials_resource:62683ae5f4103fb29d38329b10654510]

Mycophenolic Acid [clinicaltrials_resource:f75b029fbf569731a07aa713250d93da]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Hypoglycemia unawareness

http://www.w3.org/2001/XMLSchema#string

Hypoglycemia

http://www.w3.org/2001/XMLSchema#string

Insulin dependence

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

link [clinicaltrials_vocabulary:link]

Click here for the Clinical Islet Transplantation Consortium Web site [clinicaltrials_resource:b8e2e1ef83cee57dfdd368ebd406d9c5]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d8672eb554339ec0310b001cb308e454]

location [clinicaltrials_vocabulary:location]

Emory University [clinicaltrials_resource:268d3425c3d686115071a98c9c2104a1]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00468403

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Islet Transplantation in Type ...... ) Maintenance Therapy (CIT-04)

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

DAIT CIT-04

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

A.M. James Shapiro, MD, PhD [clinicaltrials_resource:d8e7befc221eb545b54eba7efcba5d10]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

United States: Food and Drug Administration [clinicaltrials_resource:be4cea82cb21bbda79c939a4d720315b]

phase [clinicaltrials_vocabulary:phase]

Phase 2 [clinicaltrials_resource:56e0338b27a2d68f77402c88327b3f8d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

National Institute of Allergy and Infectious Diseases (NIAID) [clinicaltrials_resource:d9a74aeb9c0d0448f38e08189395de72]

start date [clinicaltrials_vocabulary:start-date]

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00468403 study design [clinicaltrials_resource:b8c9cec8e684eacafb25f6330964da4f]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00468403

verification date [clinicaltrials_vocabulary:verification-date]

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00468403

http://www.w3.org/2001/XMLSchema#string

title

LEA29Y (Belatacept) Emory Edmonton Protocol

@en